Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease
Movement Disorders2004Vol. 20(3), pp. 383–385
Citations Over TimeTop 10% of 2004 papers
Abstract
Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability.
Related Papers
- → Iron, the substantia nigra and related neurological disorders(2008)138 cited
- → Parkinson’s Disease-Overview(2021)11 cited
- → Analysis on the Effect of Heavy Metals and Genetics on the Prevalence of Parkinson’s Disease(2020)1 cited
- → Vitamin D and Parkinson's disease(2023)1 cited
- → Quantitative Evaluation of Substantia Nigra Degeneration in Parkinson’s Disease using T1 mapping(2023)